Purdue Pharma Net Worth: A Look at the Company's History and Controversy

Purdue Pharma, the company behind the opioid painkiller OxyContin, has a complex and tumultuous history. The company was founded in 1849 by two brothers, George and Isaac Ryder, but it wasn't until 1996 that Purdue Pharma introduced OxyContin, which would become its most profitable product.

Purdue Pharma's net worth grew significantly in the late 1990s and early 2000s, with the company's annual revenue reaching $3.1 billion by 2002. This was largely due to the massive sales of OxyContin, which was initially marketed as a safer alternative to other painkillers.

The company's aggressive marketing tactics and lack of transparency about the risks of OxyContin have been widely criticized. As a result, Purdue Pharma has faced numerous lawsuits and settlements, including a $634 million payment in 2007 to resolve claims that the company had downplayed the risks of OxyContin.

The Sackler family, who own Purdue Pharma, have been at the center of the controversy surrounding the company. They have been accused of using their wealth and influence to silence critics and avoid accountability for the opioid crisis.

The Sackler family's net worth is a staggering $11 billion.

This amount is based on an investigation by the US House of Representatives oversight committee in 2021.

The Sackler family's wealth comes from owning a controlling share of Purdue Pharma since 1952.

They had withdrawn over €9 billion from Purdue while the opioid crisis was erupting.

The Sacklers' complicated ownership of the estate is a topic of controversy. Public filings don't show who actually owns the estate.

Gardeners at the site were tight-lipped about the ownership, refusing to answer questions. Documents leaked from Appleby, a Bermuda law firm employed by numerous wealthy clients, reveal that the companies belong to the Sacklers.

The Sacklers control at least 30 island-based entities through family trusts. The trustee of the British estate also controls a Sackler company named in U.S. securities filing as one of Purdue's two "ultimate parents."

Some states have sued Beacon Co., a firm based in the Channel Islands, along with Purdue and the Sacklers. New York state is seeking to subpoena the offshore trust company used to control both Beacon and the British estate.

The Sacklers use Bermuda as a base for Mundipharma, a network of companies set up to do business outside North America. They also have family foundations, real estate holding companies, and an insurer in the island portfolio.

Mortimer D.A. Sackler wrote to his cousins, "I would not count out the possibility that times will get much more difficult again in the future and probably much sooner than we expect."

Broaden your view: List of Largest Companies in the United Kingdom

The Sackler Family was at the helm of Purdue Pharma, with notable members including former CEO Raymond Sackler, former President Richard Sackler, former Co-Chair Mortimer Sackler, and Arthur Sackler Sr.

Arthur Sackler Sr, a key figure in the family, was a founding member of Purdue Pharma.